InvestorsHub Logo
Followers 21
Posts 635
Boards Moderated 0
Alias Born 11/08/2018

Re: HDGabor post# 266739

Thursday, 04/16/2020 2:49:29 PM

Thursday, April 16, 2020 2:49:29 PM

Post# of 425939
Amarin clearly had no choice but to go to trial to protect their patents i-the generics were unprepared to settle - the stakes were too high for generics to settle for a long off entry /pay their fees deal - they wanted the long shot go at winning - and In litigation nothing is certain -and boy they got very lucky
They can now sit and wait and do nothing - hope amarin loses appeal and they are in -all a long shot and taken a little time but cost them peanuts to get this far
Amarin has no option but to continue with appeal - win it and they are back on track - loose it and they are in reality no worse off than they are now - they can try delay generics coming in threaten their own generic launch and so forth - they have Europe and rest of world to work on
Maybe not as great as it could have been but they will just keep on going and make the best of it
Settlement now ... no chance - amarin are just moving on and their primary driver is to endeavour to cover every corner of the appeal to ensure that this time that it is the generics that are on the wrong side of litigation - and at the same time taking every step to ensure the generics are wrong footed if and when they do try and enter market
Alm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News